Market News AIOpen the app

DNTH stock news · Dianthus Therapeutics, Inc.

Stories about Dianthus Therapeutics, Inc. (DNTH) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for DNTH

Follow Dianthus Therapeutics, Inc. (DNTH) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for DNTH
Free on the App Store and Google Play, or on the web.
  1. Nov 4, 2026, 2:41 PM ET · Market

    Dianthus Therapeutics will share its Q3 2026 financial results on November 5, 2026.

    Neutral

    Dianthus scheduled its Q3 2026 results for November 5 at 7:00 AM ET; analysts expect $460,930 in sales and a $0.94 loss per share. No results are reported yet, so this does not change its outlook.